Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Analgesic nephropathy (painkillers and the kidneys) [[electronic resource]]
| Analgesic nephropathy (painkillers and the kidneys) [[electronic resource]] |
| Pubbl/distr/stampa | Bethesda, MD : , : National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services, , [2007] |
| Descrizione fisica | 2 unnumbered pages : digital, PDF file |
| Collana | NIH publication |
| Soggetto topico |
Nephritis, Interstitial - Etiology
Analgesics Kidneys - Diseases - United States Blood - Diseases |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Analgesic nephropathy |
| Record Nr. | UNINA-9910698982903321 |
| Bethesda, MD : , : National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tubulointerstitial nephritis / / Mohamed G. Atta and Mark A. Perazella, editors
| Tubulointerstitial nephritis / / Mohamed G. Atta and Mark A. Perazella, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (344 pages) |
| Disciplina | 616.612 |
| Soggetto topico |
Nephritis, Interstitial
Nephritis, Interstitial - Etiology Nephrology |
| ISBN | 3-030-93438-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- Contributors -- Part I: History and Epidemiology -- Tubulointerstital Nephritis: A History of Its Conceptual Evolution -- 1 Foundations -- 1.1 Acute Interstitial Nephritis -- 1.2 Chronic Tubulointerstitial Nephritis -- Suggested Reading -- Epidemiology of Tubulointerstitial Nephritis -- 1 Introduction -- 2 Incidence of Interstitial Nephritis -- 3 Etiology of AIN -- 4 Drug Induced AIN -- 5 Endemic Nephritis -- 6 Conclusion -- Suggested Reading -- Part II: Pathogenesis -- Pathogenesis of Acute Tubulointerstitial Nephritis -- 1 Introduction -- 2 Immune ATIN -- 3 Allergic ATIN -- 4 Toxic ATIN -- 4.1 Aristolochic Acid -- 4.1.1 Cellular Toxicity and Inflammation and Fibrosis -- 4.2 Cellular Toxicity -- 4.3 Inflammation and Fibrosis -- 4.4 Heavy Metals -- 4.5 Transport and Uptake -- 4.6 Toxicity -- 4.7 Lithium -- 5 Metabolic ATIN -- 5.1 Uric Acid -- 5.2 Oxalate -- 5.3 Hypokalemia -- 6 Genetic ATIN -- 6.1 Karyomegalic Interstitial Nephritis -- 6.2 Familial Nephronophthisis -- 6.3 Tubulointerstitial-Uveitis Syndrome (TINU) -- 6.4 Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) -- 7 Infiltrative ATIN -- 7.1 Sjogren's Syndrome -- 7.2 Sarcoidosis -- 7.3 Systemic Lupus Erythematosus (SLE) Nephritis -- 7.4 IgG4 Disease -- Suggested Reading -- Part III: Causes of Immune Mediated Tubulointerstitial Nephritis -- Causes of Acute Tubulointerstitial Nephritis: Drugs -- 1 Introduction -- 2 Antimicrobials -- 3 Non-steroidal Anti-inflammatory Drugs -- 4 Proton-Pump Inhibitors -- 5 5-Aminosalicylates -- 6 Anticancer Drugs -- 6.1 Immune Checkpoint Inhibitors -- 6.2 Tyrosine Kinase Inhibitors -- 6.3 Platinum Agents -- 6.4 Ifosfamide -- 6.5 Other Anticancer Agents -- 7 Other Drugs -- 8 Conclusions -- Suggested Reading -- Viral-Induced Tubulointerstitial Nephritis -- 1 Hantavirus Nephropathy -- 2 Human Immunodeficiency Virus (HIV) Infection.
3 BK Virus-Associated Nephropathy -- 4 Adenoviral Nephritis -- 5 Cytomegalovirus (CMV) Interstitial Nephritis -- Suggested Reading -- Bacterial and Parasitic-Related Tubulointerstitial Nephritis -- 1 Introduction -- 2 Bacterial Causes of Interstitial Disease -- 2.1 Mycobacterium tuberculosis -- 2.2 Leptospirosis -- 2.3 Leprosy -- 3 Parasitic Causes of Interstitial Nephritis -- 3.1 Mechanisms by Which Parasites Affect the Kidney -- 4 Conclusion -- Suggested Reading -- Tubulointerstitial Nephritis Due to Autoimmune Diseases -- 1 Introduction -- 2 Sarcoidosis -- 2.1 Pathology -- 2.2 Treatment and Prognosis -- 3 Systemic Lupus Erythematosus -- 3.1 Pathology -- 3.2 Treatment and Prognosis -- 4 Tubulointerstitial Nephritis and Uveitis -- 4.1 Pathology -- 4.2 Treatment and Prognosis -- 5 Sjogren's Syndrome -- 5.1 Pathology -- 5.2 Treatment and Prognosis -- 6 ANCA-Associated Vasculitis -- 6.1 Pathology -- 6.2 Treatment and Prognosis -- 7 Other Autoimmune Diseases -- 8 Conclusions -- Suggested Reading -- IgG4-Related Tubulointerstitial Kidney Disease -- 1 Overview of IgG4-Related Disease (IgG4-RD) -- 2 IgG4-Related Kidney Disease (IgG4-RKD) -- 3 Clinical Manifestations of IgG4-RKD -- 3.1 IgG4-Tubulointerstitial Nephritis -- 3.2 IgG4-Related Membranous Glomerulonephritis -- 4 Radiologic Findings in IgG4-TIN -- 5 The Spectrum of the Pathology of IgG4-RKD -- 5.1 Tubulointerstitial and Vascular Involvement -- 5.2 Glomerular Involvement -- 6 Treatment and Prognosis of IgG4-RKD -- 7 The Pathogenesis of IgG4-RD -- Suggested Reading -- Anti-Brush Border Antibody (ABBA)-Associated Tubulointerstitial Disease -- Suggested Reading -- Transplant Rejection and Infection Associated Tubulointerstitial Nephritis -- 1 Introduction -- 2 Transplant Rejection Associated Tubulointerstitial Nephritis -- 2.1 Presentation -- 2.2 Pathology -- 2.3 Treatment. 3 Transplant Infection Associated Tubulointerstitial Nephritis -- 3.1 Cytomegalovirus Associated TIN -- 3.2 Presentation -- 3.3 Pathology -- 3.4 Treatment -- 3.5 BK Virus-Associated TIN -- 3.5.1 Presentation -- 3.5.2 Pathology -- 3.5.3 Treatment -- 3.6 Adenovirus Associated TIN -- 3.6.1 Presentation -- 3.6.2 Pathology -- 3.6.3 Treatment -- 4 Conclusion -- Suggested Reading -- Part IV: Causes of non-Immune Mediated Tubulointerstitial Nephritis -- Genetic Diseases Associated with Tubulointerstitial Nephritis -- 1 Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) -- 1.1 Clinical Description -- 1.2 Kidney Biopsy -- 1.3 Epidemiology -- 1.4 Pathophysiology -- 1.5 Molecular Genetic Diagnosis -- 1.6 Therapies -- 2 Nephronophthisis -- 2.1 Epidemiology and Clinical Description -- 2.2 Laboratory Studies and Kidney Biopsy -- 2.3 Physiology and Pathophysiology -- 2.4 Diagnosis -- 2.5 Therapies -- 3 Differential Diagnosis -- 4 Other Genetic Diseases of Interest -- 5 Conclusion -- Suggested Reading -- Cystinosis -- 1 Introduction -- 2 Genetics -- 3 Kidney Pathology -- 4 Clinical Manifestations -- 4.1 Kidney Disease -- 4.2 Ocular Involvement -- 4.3 Growth Impairment -- 4.4 Other Clinical Findings -- 5 Diagnosis and Treatment -- 5.1 Symptomatic Therapy -- 5.2 Specific Treatment -- Suggested Reading -- Chronic Tubulointerstitial Nephritis: Hypokalemia, Hyperoxaluria, and Hyperuricemia -- 1 Introduction -- 2 Hypokalemic Chronic Interstitial Nephritis -- 2.1 Epidemiology -- 2.2 Pathophysiology -- 2.3 Histopathology -- 2.4 Clinical Picture -- 2.5 Treatment -- 3 Oxalate Nephropathy -- 3.1 Epidemiology -- 3.2 Pathophysiology -- 3.3 Histopathology -- 3.4 Clinical Presentation -- 3.5 Treatment -- 4 Uric Acid Nephropathy -- 4.1 Epidemiology -- 4.2 Pathophysiology -- 4.3 Histopathology -- 4.4 Clinical Presentation -- 4.5 Treatment -- 5 Conclusion. Suggested Reading -- Non-immunological Causes of Tubulointerstitial Disease -- 1 Historical Perspectives -- 2 Heavy Metal Toxicity -- 2.1 Lead -- 2.2 Cadmium -- 2.2.1 Diagnosis of Cadmium Toxicity -- 2.2.2 Treatment of Cadmium Toxicity -- 2.3 Arsenic -- 2.4 Chromium -- 2.5 Mercury -- 2.6 Uranium -- 2.7 Treatment of Heavy Metal Toxicity -- 3 Plants, Mushrooms, and Herbal Medications -- 4 Therapeutic Agents -- 5 Radiation -- 6 Chronic Kidney Disease of Unknown Etiology (CKDu) -- 7 Conclusion -- Suggested Reading -- Reflux and Obstructive Nephropathy -- 1 Introduction -- 2 Etiology -- 3 Clinical Presentation -- 4 Diagnosis -- 5 Management -- Suggested Reading -- Aristolochic Acid Nephropathy and Balkan Nephropathy -- 1 Introduction -- 1.1 Aristolochia Species -- 2 The Toxicity of Aristolochic Acids -- 3 Natural History of the Disease -- 4 Kidney Pathology -- 5 Diagnosis -- 6 Prevention -- 7 Treatment -- Suggested Reading -- Chronic Kidney Disease of Unknown Etiology -- 1 The Disease and Its Toll -- 2 Pathology Findings -- 3 Investigations into Cause: Major Hypotheses of Interest -- 3.1 Social Determinants -- 3.2 Heat Stress and Dehydration -- 3.3 Agrochemical and Metals -- 3.4 Genetics -- 3.5 Use of Anti-inflammatory Drugs -- 3.6 Infectious Diseases -- 4 Ongoing Research Efforts -- 5 Summary -- Suggested Reading -- Infiltrative Disease of the Tubulointerstitium -- 1 Infiltrative Diseases of the Tubulointerstitium -- 2 Lymphoproliferative Disorders -- 2.1 Lymphomatous Infiltrates -- 2.2 Lymphoplasmacytic Lymphomas -- 2.3 Leukemic Infiltrates -- 2.4 Plasma Cell Dyscrasia Associated Infiltrative Diseases -- 2.5 Immunodeficiency Related Lymphoproliferative Disorders of the Kidney -- 3 Solid Cancers -- 3.1 Renal Cell Carcinoma -- 3.2 Urothelial Carcinomas -- 3.3 Primary Renal Sarcoma -- 3.4 Metastases to the Kidneys -- 3.5 Pediatric Kidney Tumors. Suggested Reading -- Part V: Diagnosis -- Clinical Features and Laboratory Findings in Acute Tubulointerstitial Nephritis -- 1 Introduction -- 2 Clinical Features -- 3 Serum Tests -- 4 Urine Findings -- 5 Imaging Tests -- 6 Novel Serum and Urine Biomarkers -- Suggested Reading -- Imaging Modalities for Acute Tubulointerstitial Nephritis -- 1 Introduction -- 2 Ultrasonography -- 3 Computed Tomography Imaging -- 4 67Gallium Scintigraphy -- 5 Positron Emission Tomography-CT Imaging -- 6 Magnetic Resonance Imaging -- 7 Conclusion -- Suggested Reading -- Pathology of Tubulointerstitial Nephritis -- 1 Introduction -- 2 Allergic/Drug-Induced Interstitial Nephritis -- 3 Infectious Interstitial Nephritis -- 3.1 Viral Infections -- 3.2 Bacterial Infections (Pyelonephritis) -- 3.2.1 Xanthogranulomatous Pyelonephritis, Malakoplakia, Megalocytic Interstitial Nephritis -- 4 Granulomatous Interstitial Nephritis -- 5 Autoimmune Tubulointerstitial Nephritis -- 6 Immune Complex-Mediated Tubulointerstitial Nephritis -- 7 Other Autoimmune Tubulointerstitial Nephritis -- 8 Chronic Interstitial Nephropathies -- 9 Hereditary, Metabolic and Other Types of Tubulointerstitial Nephritis -- 10 Mimics of Tubulointerstitial Nephritis -- Suggested Reading -- Part VI: Treatment -- Management of Tubulointerstitial Nephritis -- 1 Introduction -- 2 Identifying and Removing the Culprit Drug -- 3 Treatment with Corticosteroids -- 4 Corticosteroid Use Versus Conservative Management -- 4.1 DI-AIN -- 5 Intravenous Versus Oral Route of Corticosteroids -- 6 Length of Corticosteroid Therapy -- 7 Length of Corticosteroid Taper -- 8 Alternative Therapies for AIN -- 9 Conclusions -- Suggested Reading -- Part VII: Prognosis/Outcomes -- Prognosis and Outcomes of Acute Tubulointerstitial Nephritis -- 1 Introduction -- 2 Overall Renal Outcomes -- 3 Risk Factors for Adverse Renal Outcome. 4 Corticosteroids and Renal Outcome. |
| Record Nr. | UNINA-9910556883403321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
